Friday, 11 December 2009

Development of new formulation at Meda Pharmaceutical

The Meda Pharmaceutical is focused primarily on respiratory, allergy, central nervous system, cough-cold, musculoskeletal, and rheumatology.

MEDA AB is an international specialty pharma company that concentrates on marketing and market-adapted product development. Acquisitions and long-term partnerships are fundamental factors that drive the company’s strategy.

For more info visit http://www.medapharma.us/index.html

No comments: